Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04367467 · ClinicalTrials.gov registry record
Effect of PARP Inhibitors on Glomerular Filtration Rate
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04367467: Clinical Trial study, sponsored by University of Pennsylvania.
NCT04367467 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04367467 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to observe whether PARP inhibitors have an effect on serum creatinine level, and whether this reflects a change in creatinine secretion or a true change in kidney function.
Primary Outcome
Change in eGFR from baselineto on-treatment by ≥20% as measured using either cystatin C or 24h urine collection
Interventions
- OTHER Kidney Function Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2021-07-01 |
Why NCT04367467 stopped before completion
NCT04367467 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Kidney Function Test is the first listed.
NCT04367467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04367467 about?
NCT04367467 is a clinical study titled "Effect of PARP Inhibitors on Glomerular Filtration Rate". The purpose of this study is to observe whether PARP inhibitors have an effect on serum creatinine level, and whether this reflects a change in creatinine secretion or a true change in kidney function.
What is the current status of trial NCT04367467?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2020-02-03. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT04367467?
The interventions under investigation include: Kidney Function Test (OTHER).
Who is sponsoring clinical trial NCT04367467?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI